Role of PAPP-A in Atherosclerosis

PAPP-A 在动脉粥样硬化中的作用

基本信息

  • 批准号:
    7637227
  • 负责人:
  • 金额:
    $ 37.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-01 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal focuses on a newly recognized zinc metalloproteinase in the insulin-like growth factor (IGF) regulatory system, so-called pregnancy-associated plasma protein-A (PAPP-A), and its role in atherosclerosis. IGFs play a critical role in the vascular injury response through their potent and varied receptor-mediated effects on proliferation, migration, survival and differentiated cell function. PAPP-A is secreted by and binds to vascular cells, and, by proteolytic cleavage of local inhibitory IGF binding proteins, can increase the pericellular IGF available for receptor activation within the developing lesion. Strong PAPP-A immunoreactivity co-localizing with activated smooth muscle cells and macrophages has been demonstrated in vulnerable plaques of humans who had died of myocardial infarction with little or no staining in stable plaques. In addition, elevated serum PAPP-A is under consideration as a biomarker of acute coronary syndro muscle show accelerated atherosclerotic lesion development. Our overall hypothesis is that PAPP-A is a key regulatory factor promoting atherosclerotic plaque development and plaque vulnerability. Utilizing novel transgenic and conditional gene knock-out mice, the SPECIFIC AIMS of this proposal are to: 1. Ascertain the structural determinants of PAPP-A necessary for its ability to enhance atherosclerotic plaque development. 2. Determine the effect of PAPP-A deficiency on established atherosclerotic plaque. 3. Determine the effect of PAPP-A overexpression on plaque vulnerability. The proposed studies seek to gain a better understanding of PAPP-A in the fundamental biology of atherosclerosis, and should establish a scientific basis for novel strategies to identify and limit, and possibly reverse, plaque growth and vulnerability in atherosclerosis. PUBLIC HEALTH RELEVANCE: Atherosclerosis is the major cause of death in westernized societies. The proposed studies seek to gain a better understanding of a newly discovered enzyme implicated in atherosclerotic lesion development and should establish a scientific basis for novel strategies to identify and limit, and possibly reverse, atherosclerosis.
描述(由申请人提供):本提案重点关注胰岛素样生长因子(IGF)调节系统中新发现的锌金属蛋白酶,即妊娠相关血浆蛋白-A(PAPP-A)及其在动脉粥样硬化中的作用。IGFs通过其对增殖、迁移、存活和分化细胞功能的有效和多种受体介导的作用在血管损伤反应中发挥关键作用。PAPP-A由血管细胞分泌并与血管细胞结合,并且通过局部抑制性IGF结合蛋白的蛋白水解裂解,可以增加可用于发展中病变内受体活化的细胞周IGF。已在死于心肌梗死的人的易损斑块中证实了与活化的平滑肌细胞和巨噬细胞共定位的强PAPP-A免疫反应性,在稳定斑块中几乎没有染色或没有染色。此外,血清PAPP-A升高被认为是急性冠状动脉综合征的生物标志物,肌肉显示加速动脉粥样硬化病变的发展。我们的总体假设是PAPP-A是促进动脉粥样硬化斑块发展和斑块易损性的关键调节因子。利用新的转基因和条件基因敲除小鼠,本提案的具体目的是:1。确定PAPP-A增强动脉粥样硬化斑块发展能力所必需的结构决定因素。2.确定PAPP-A缺乏对已形成的动脉粥样硬化斑块的影响。3.确定PAPP-A过表达对斑块易损性的影响。拟议的研究旨在更好地了解动脉粥样硬化基础生物学中的PAPP-A,并为识别和限制,并可能逆转动脉粥样硬化斑块生长和脆弱性的新策略建立科学基础。公共卫生相关性:动脉粥样硬化是西方社会的主要死亡原因。拟议的研究旨在更好地了解一种新发现的与动脉粥样硬化病变发展有关的酶,并为识别和限制甚至逆转动脉粥样硬化的新策略建立科学基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cheryl A. Conover其他文献

Pregnancy-Associated Plasma Protein-A Elevation in Patients With Acute Coronary Syndrome and Subsequent <em>Atorvastatin</em> Therapy
  • DOI:
    10.1016/j.amjcard.2007.07.045
  • 发表时间:
    2008-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Michael D. Miedema;Cheryl A. Conover;Holly MacDonald;Sean C. Harrington;Dedra Oberg;Daniel Wilson;Timothy D. Henry;Robert S. Schwartz
  • 通讯作者:
    Robert S. Schwartz
Transforming growth factor-b 1 modulates insulin-like growth factor binding protein-4 expression and proteolysis in cultured periosteal explants
转化生长因子-b 1 调节培养的骨膜外植体中胰岛素样生长因子结合蛋白-4 的表达和蛋白水解
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Carlos González;Kiem G. Auw Yang;Joseph H. Schwab;J. Fitzsimmons;M. Reinholz;Zachary T. Resch;L. Bale;Victoria R. Clemens;Cheryl A. Conover;Shawn W. O'Driscoll;G. G. Reinholz
  • 通讯作者:
    G. G. Reinholz
Genetic and Pharmacological Inhibition of PAPP-A Reduces Bleomycin-Induced Pulmonary Fibrosis in Aged Mice via Reduced IGF Signaling
PAPP-A 的遗传和药理学抑制通过减少 IGF 信号传导减少老年小鼠博莱霉素诱导的肺纤维化
  • DOI:
    10.59368/agingbio.20240023
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Cheryl A. Conover;L. Bale;Sally A. West;Claus Oxvig;Kristian S. Andersen;A. Roden;A. Haak
  • 通讯作者:
    A. Haak
Pregnancy associated plasma protein-A is preferentially expressed in plaque of patients with restenosis
  • DOI:
    10.1016/s0735-1097(02)80083-3
  • 发表时间:
    2002-03-06
  • 期刊:
  • 影响因子:
  • 作者:
    Ali E. Denktas;Kristen Shogren;David R. Holmes;Antoni Bayes-Genis;Claus Oxvig;Michael T. Overgaard;Michael Christiansen;Cheryl A. Conover;Robert S. Schwartz
  • 通讯作者:
    Robert S. Schwartz
Hodgkin’s Lymphoma Manifesting with Hypoglycemia
  • DOI:
    10.4158/ep.9.1.96
  • 发表时间:
    2003-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Cacia V. Soares-Welch;Steven R. Zeldenrust;Cheryl A. Conover;Clive S. Grant;F. John Service
  • 通讯作者:
    F. John Service

Cheryl A. Conover的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cheryl A. Conover', 18)}}的其他基金

Role of PAPP-A in Graves' Ophthalmopathy
PAPP-A 在格雷夫斯眼病中的作用
  • 批准号:
    10651452
  • 财政年份:
    2023
  • 资助金额:
    $ 37.78万
  • 项目类别:
PAPP-A as a Potential Target in Alzheimer's Disease
PAPP-A 作为阿尔茨海默病的潜在靶点
  • 批准号:
    10577483
  • 财政年份:
    2022
  • 资助金额:
    $ 37.78万
  • 项目类别:
Role of PAPP-A in Pulmonary Fibrosis
PAPP-A 在肺纤维化中的作用
  • 批准号:
    10261323
  • 财政年份:
    2020
  • 资助金额:
    $ 37.78万
  • 项目类别:
Postdoctoral Training Program for Research on Aging
老龄化研究博士后培养项目
  • 批准号:
    9406898
  • 财政年份:
    2016
  • 资助金额:
    $ 37.78万
  • 项目类别:
Postdoctoral Training Program for Research on Aging
老龄化研究博士后培养项目
  • 批准号:
    9272791
  • 财政年份:
    2016
  • 资助金额:
    $ 37.78万
  • 项目类别:
Role of PAPP-A in Atherosclerosis
PAPP-A 在动脉粥样硬化中的作用
  • 批准号:
    8220837
  • 财政年份:
    2009
  • 资助金额:
    $ 37.78万
  • 项目类别:
Role of PAPP-A in Atherosclerosis
PAPP-A 在动脉粥样硬化中的作用
  • 批准号:
    7808809
  • 财政年份:
    2009
  • 资助金额:
    $ 37.78万
  • 项目类别:
Role of PAPP-A in Atherosclerosis
PAPP-A 在动脉粥样硬化中的作用
  • 批准号:
    8051556
  • 财政年份:
    2009
  • 资助金额:
    $ 37.78万
  • 项目类别:
Dissection of the IGF-Longevity Connection in a Novel Mouse Model
新型小鼠模型中 IGF-长寿连接的剖析
  • 批准号:
    7798008
  • 财政年份:
    2007
  • 资助金额:
    $ 37.78万
  • 项目类别:
Dissection of the IGF-Longevity Connection in a Novel Mouse Model
新型小鼠模型中 IGF-长寿连接的剖析
  • 批准号:
    7193021
  • 财政年份:
    2007
  • 资助金额:
    $ 37.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了